Cannvas Establishes Industry Framework for Cannabis Data Reports & Analytics

Self-Serve Delivery System for Canadian and Global Cannabis Market Data

TORONTO, Sept. 6, 2018 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC, Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce it has established an industry framework for data reporting and analytics for the Canadian and global cannabis marketplace. Data and information captured through Cannvas.me, a global cannabis education platform, will be presented through a self-serve delivery system with innovative forms of information filtering and processing for enhanced insight and decision making.

"By leveraging our knowledge of advanced technology and consumer marketing we have created the tools to provide stakeholders in the Canadian and global cannabis market with the ability for evidence-based decision making," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech. "The cannabis industry is in the very early stage of development and is lacking a central database for researchers, healthcare professionals, licensed producers and other industry stakeholders to gain access to real industry insights. Cannvas Data will produce data analytics and trend analysis on global consumer data and cannabis industry benchmarks. Data points such as consumption, health and wellness, demographics and geo-location are examples of what will be captured and analyzed for the multiple integrated verticals of the cannabis industry, empowering decision making with accurate, timely and insightful results."

Data is a major priority for corporations of all sizes. By using advanced technology, machine learning algorithms and artificial intelligence, Cannvas Data will analyze the large data sets captured from Cannvas.me online platform. The data originating from Cannvas.me, clinical and academic research, government reports and other sources will contain a broad spectrum of data points types, that when analyzed will uncover market trend, hidden patterns, unknown correlations, customer preferences and other valuable business information.

About Cannvas Data
Cannvas Data is pioneering to be the census data of the cannabis industry by leveraging advanced technology, machine learning algorithms and scientific and medical research data to provide meaningful insights to the global cannabis community. Operating as part of the Cannvas.me platform, Cannvas Data analyzes a multitude of data points captured from those usering medical and recreational cannabis to improve their health and wellness. The platform is LP/REC agnostic which means it is not biased by the personal drivers of any one company or institution, and it is continuously evolving and adapting to users and recognizing and learning from changing trends. For more information visit: www.cannvasdata.com

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

For additional information:
www.cannvasmedtech.com

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

SOURCE Cannvas MedTech Inc.

Media Inquiries: [email protected]; Investor Relations: [email protected], 1-800-489-0116